Our findings highlight CHP1 as a novel prognostic biomarker and functional mediator in ccRCC, with roles in amino acid metabolism, transcriptional regulation, immune cell interaction, and potential drug targeting. This evidence concerns the gene CHP1 and nonpapillary renal cell carcinoma.